Human brain organoids represent a powerful tool for the study of human neurological diseases particularly those that impact brain growth and structure. However, many neurological diseases lack obvious anatomical abnormalities, yet significantly impact neural network functions, raising the question of whether organoids possess sufficient neural network architecture and complexity to model these conditions. Here, we explore the network level functions of brain organoids using calcium sensor imaging and extracellular recording approaches that together reveal the existence of complex oscillatory network behaviors reminiscent of intact brain preparations. We further demonstrate strikingly abnormal epileptiform network activity in organoids derived from a Rett Syndrome patient despite only modest anatomical differences from isogenically matched controls, and rescue with an unconventional neuromodulatory drug Pifithrin-a. Together, these findings provide an essential foundation for the utilization of human brain organoids to study intact and disordered human brain network formation and illustrate their utility in therapeutic discovery.
INTRODUCTION
Brain organoids derived from human pluripotent stem cells have been shown to recapitulate unique features of human brain development and are increasingly being used as model systems to gain novel insights into a variety of neurological diseases [1] [2] [3] . Organoids represent a significant development in the toolkit available for of our understanding of brain function and disease mechanisms as much of our current knowledge is derived from studies of embryonic and adult animals, particularly rodents. While there is a great deal of conservation in the overall mechanisms of brain development across evolution, it has become increasingly clear that the human brain possesses many distinct features that are not shared with other species 4, 5 , and it remains unclear how well animal models of neurological disease faithfully recapitulate human pathologies. Moreover, neuromodulatory drugs shown to be effective in ameliorating neurological disease in animals frequently fail when brought to clinical trials 6, 7 , emphasizing the need for human cell-based systems to help evaluate drug efficacy.
Most brain organoid studies to date have capitalized on the anatomical and cytoarchitectural characteristics of the organoid to model disorders that grossly impact the growth or organization of the human brain such as microcephaly, macrocephaly, and lissencephaly [1] [2] [3] . However, the diverse functions of the human brain depend not only on its stereotyped anatomical structure, but also on the establishment and function of neural microcircuits, and their assembly into neural networks. Indeed, errors in the initial formation of these circuits or damage after their appropriate development are thought to underlie a number of neurological diseases ranging from autism spectrum and neuropsychiatric disorders to epilepsy and Alzheimer's disease 8, 9 . Reliably assessing network activity becomes especially critical in those situations in which there is clear clinical disease but no overt structural brain abnormality. 4 Despite ample evidence of the structural complexity of brain organoids, the presence of sophisticated neural network activities has not been comprehensively demonstrated in live whole-organoid preparations. A key identifying feature of robust neural networks is the presence of distinct frequencies of oscillatory activity. Such activities are thought to depend on precisely tuned inhibitory-excitatory neuronal interactions and can be recorded from intact brain preparations, but are not readily achievable in two-dimensional culture systems 10, 11 . In addition, specific changes in oscillatory activity, such as the loss of gamma activity or the emergence of polymorphic low frequency activity, can be clear indicators of underlying neurological dysfunction [12] [13] [14] .
In the following study we sought to develop and characterize brain organoid network activity utilizing recent advances in organoid techniques 15 to generate cerebral cortex-ganglionic eminence (Cx+GE) "fusion" organoids in which excitatory and inhibitory neurons functionally integrate [16] [17] [18] . We then used a combination of calcium sensor imaging and extracellular recordings of local field potentials to demonstrate the presence of sophisticated network-level activities including oscillatory rhythms. These techniques allowed us to clearly discern pathological network and oscillatory changes in fusion organoids containing a mutation in the Methyl-CpG Binding Protein 2 (MECP2) gene associated with Rett syndrome 19 . Collectively, these findings provide a framework for how brain organoids can be utilized to investigate the network-level functions of the human brain and illustrate their utility in modeling neurological disorders.
RESULTS

Fusion of cortex and ganglionic eminence organoids permits the assembly of abundant excitatory and inhibitory synaptic connections
As cortical circuits in vivo contain a mixture of both excitatory and inhibitory connections, we sought to replicate this process using an organoid "fusion" technique to combine separately generated cortical and subcortical organoids and create an integrated structure ( Fig. 1 and Extended Data Fig. 1 ). Organoids were directed towards cortex (Cx) or ganglionic eminence (GE) identities through the absence or presence of Sonic hedgehog (Shh) pathway agonists in the organoid differentiation scheme ( Fig. 1a) 15 . In the absence of Shh signaling, organoids predominantly exhibited cortical character including expression of the apical and basal radial glial progenitor marker PAX6, the intermediate progenitor marker TBR2 (EOMES), deep cortical plate markers including TBR1, CTIP2 (BCL11B), and BHLHB5 (BHLHE22), and superficial layer markers such as SATB2, and BRN2 (POU3F2) ( Fig. 1b and Fig. 3a ). Shh pathway-stimulated organoids by contrast expressed canonical GE progenitor and migratory interneuron markers such as NKX2.1, DLX1, DLX2, and OLIG2. Over time in culture, many neurons within the GE organoids expressed the general GABAergic inhibitory neuron marker GAD65 along with a variety of interneuron subtype markers including somatostatin (SST), calretinin, and calbindin ( Fig. 1b and Extended Data Fig. 1c ; see also 15 ).
In the developing forebrain in vivo, GE-derived interneurons migrate tangentially into the adjacent cortex and functionally integrate into cortical neural networks, a process that can be recapitulated in vitro [16] [17] [18] . Using adeno-associated virus (AAV)-TdTomato labeling of the GE organoid before Cx+GE fusion, we observed widespread migration of TdTomato + cells originating from the GE and dispersion within the adjacent Cx two weeks after fusion (Fig. 1a,   6 c). Minimal TdTomato + cell migration was seen in control Cx+Cx or Cx+GE fusions where Cx was pre-labeled with AAV-TdTomato ( Fig. 1c ). Immunohistochemical analyses of the cortical aspect of Cx+GE fusions revealed intermingling of Cx-derived excitatory neurons, exemplified by SATB2 which is not expressed within GE organoids, and inhibitory interneurons identified by GAD65 and DLX5 costaining ( Fig. 1d ). By contrast, Cx+Cx fusions only expressed the neuronal marker SATB2 with few if any GAD65 + DLX5 + cells (Fig. 1d ). The integration of excitatory and inhibitory interneurons within the Cx+GE organoids was further confirmed by the prominence of both excitatory synapses, distinguished by VGLUT1 and PSD95 colocalization, and inhibitory synapses visualized by VGAT and gephyrin costaining ( Fig. 1e ). Cx+Cx organoids, in comparison, predominantly contained only excitatory synapses ( Fig. 1e) showing that most inhibitory synapses in the Cx+GE organoids are GE-derived.
Cortex-ganglionic eminence fusion organoids exhibit complex neural network activities including interneuron-dependent multi-frequency oscillations
To determine the range of physiological activity in the fusion organoids, we utilized both live two-photon based calcium imaging of intact organoids and extracellular recordings of local field potentials (LFPs) ( Fig. 2a ). We applied constrained non-negative matrix factorization extended (CNMF-E) methods for calcium signal processing to extract spiking dynamics from records 20 
Rett syndrome fusion organoids exhibit hypersynchronous neural network activities
We next used this platform to measure pathophysiological changes associated with human neurological disease. Rett syndrome is a neurodevelopmental disorder typically caused by de novo mutations in one copy of the MECP2 gene on the X chromosome, where affected females 8 exhibit symptoms as early as seven months of age 25 . Rett female patients exhibit motor delays, cognitive and neuropsychiatric disturbances, autism, and epilepsy 25 . However, these changes likely present well before clinical symptoms. For example, a recent hiPSC-based study has suggested that Rett may impact prenatal neurogenesis through microRNA-mediated changes in AKT and ERK activity 26 . Interestingly, while neuroanatomical changes in dendritic arborization and spine density have been reported in multiple Rett models 25, [27] [28] [29] [30] , gross structural abnormalities are less prevalent.
Due to random X-chromosome inactivation, Rett patients are typically mosaic in their MECP2 status, with some cells expressing and others lacking a functional MECP2 allele. This feature permitted the generation of isogenic hiPSC from a single patient as hiPSC reprograming does not revert X-chromosome silencing 30 . We accordingly generated Cx and GE organoids from isogenic control (iCtrl) and MECP2-mutant (Mut) Rett syndrome patient hiPSC and found no obvious differences in their cytoarchitecture or cell composition (Fig. 3, a 31 . VGLUT1/PSD95 costaining showed that the abundance of excitatory synapses was nevertheless slightly increased in Mut fusion organoids relative to iCtrl, while VGAT/gephyrin + inhibitory synapses were not significantly different (Fig. 3 , e and f), suggesting that the Mut fusion organoids may be prone to hyperexcitability.
More striking, however, were activity differences revealed though GCaMP6f imaging. Supplementary Videos 4-5) and the epileptiform changes seen in murine models of Rett syndrome 32 . Previous reports have indicated increased overall activity and diminished size of neural microcircuits in mouse chemoconvulsant epilepsy models 33 . We similarly observed that the increased synchronization of calcium transients in Mut Cx+GE organoids was accompanied by reductions in both the size of microcircuit clusters and the number of neurons within each cluster (Extended Data Fig. 4a ). and instead exhibited recurring epileptiform-appearing spikes and high frequency oscillations (HFOs, ~200-500 Hz; Fig. 4 , a, d, e and Extended Data Fig. 5 ). These findings concurred with calcium imaging data which showed rare but large high amplitude calcium synchronizations in Mut fusion organoids that could result in spikes or HFOs, as opposed to the numerous small synchronizations seen in iCtrl samples which likely generate sustained lower frequency oscillations without epileptiform events ( Fig. 3i and Extended Data Fig. 4b ). Hypersynchrony, HFOs, and spikes seen in Mut Cx-GE organoids are all consistent with the electrographic changes observed in human epilepsy 34, 35 . Indeed, electroencephalographic abnormalities were documented in the Rett patient whose hiPSCs were used in this study 30 .
Rett syndrome fusion organoids display deficits in low-frequency oscillations and frequent appearance of epileptiform high-frequency oscillations
Neural oscillation defects seen in Rett syndrome fusion organoids can be partially restored by administration of an unconventional neuromodulatory drug Pifithrin-a
A heralded, but largely unrealized, application of patient-derived hiPSCs is in personalized medicine. We therefore sought to determine the utility of the epileptiform phenotype observed in Rett syndrome organoids for drug testing. First, we used a broadspectrum anti-seizure medication, sodium valproate (VPA), which is commonly used to treat epilepsy resulting from Rett Syndrome 38 . We also tested the effect of a putative TP53 target inhibitor, Pifithrin-α, based on previous studies showing that MECP2 deficiency leads to overactivation of the TP53 pathway and premature neuronal senescence 30, 39 . Consistent with its known spike suppressant properties, exposure to VPA significantly reduced spiking activity in the Mut Cx+GE organoids (Fig. 5, a and c) , although it neither decreased HFOs nor restored lower frequency oscillations (Fig. 5, b and d) . Pifithrin-α similarly reduced spike frequency but remarkably also suppressed HFOs and resulted in the re-emergence of gamma oscillations ( Fig.   5, a to d) . These results suggest that unlike VPA, which appeared to merely reduce neuronal hyperexcitability, Pifithrin-α may modulate more upstream excitatory-inhibitory physiologic interactions resulting in a more global restoration of network-level functions. These findings further illustrate the potential value of the fusion organoid modeling approach in personalized drug discovery.
DISCUSSION
Collectively, these experiments demonstrate the existence of highly sophisticated physiological activities within Cx+GE organoids, congruent with their cytoarchitectural and cellular complexity. These results stand in agreement with findings recently reported by Trujillo et al, who have also observed the emergence of neural oscillations in cortical organoids cultured for prolonged time periods using a different recording approach 40 . Our studies here further demonstrate that the emergence of higher order network activities such as multi-frequency oscillations requires functional integration of inhibitory interneurons into the excitatory network framework as permitted by the organoid fusion technique, since no oscillations were apparent without them. Critically, this approach also allowed us to identify striking electrophysiological phenotypes in MECP2 mutant Cx+GE organoids despite their cytoarchitectural similarity to iCtrl samples. Nevertheless, we observed a modest increase in excitatory but not inhibitory synaptic puncta in Mut organoids consistent with their overall level of hyperactivity and hypersynchrony.
The fusion organoid approach also enabled us to demonstrate that MECP2 mutation restricted to GE derivatives, most notably inhibitory interneurons, was sufficient to drive epileptiform-like LFP changes, suggesting that multifactorial excitatory-inhibitory cell interactions underlie the MECP2-deficient phenotype. Interestingly, we achieved a more complete rescue of the Mut phenotype with a novel drug, Pifithrin-α, than was seen with a traditional anti-seizure medication, VPA, meriting future investigations into its neuromodulatory actions.
In summary, these findings illustrate the potential of brain organoids both as a unique platform for characterizing human neural networks and for personalized drug discovery and research. A remaining challenge is to delineate the precise microcircuit and cell type-specific perturbations that underlie both the oscillatory and pathological epileptiform-like changes revealed in these studies. The fusion organoid system is highly amenable to such detailed cellular and circuit analyses and provides unprecedented opportunities for modeling neural network dysfunction associated with a variety of human neurological disorders. and ganglionic eminence (GE) organoids were generated from the H9 hPSC line 41 or Rett hiPSCs 30 as described previously 15 Following initial imaging in the absence of drugs, organoids were then subjected to 1-minute incubation with the GABAA receptor antagonist gabazine (25 µM) or bicuculline methiodide (100 µM) and the identical fields were re-imaged after drug exposure.
Microcircuit identification. Raw Ca 2+ imaging files in tiff format were processed to identify fluorescence transients (ΔF/F0) and spike estimation in MATLAB (Mathworks Inc.) using the constrained non-negative matrix factorization-extended (CNMF-E) methodology 20, 21 . Following CNMF-E based data extraction neuronal microcircuit clusters were identified by performing hierarchical clustering on the correlation matrix of neuronal Ca 2+ spiking data and analyzed based on Muldoon et al. 33 . The correlation between all pair-wise combinations of the time course of spikes for all neurons identified by CNMF-E was calculated to generate a correlation matrix.
Following generation of the correlation matrix, linkage analysis was performed using the 21 MATLAB linkage function from the statistics toolbox (with 'complete'/furthest distance). The generated hierarchical clustering was input into the dendrogram function from the MATLAB statistics toolbox with 'Color Threshold' fixed at 1.5 for all experimental groups. By then assigning each neuron to a cluster determined by its assigned color in the dendrogram, clusters were created in which there was high correlation between all neurons in the cluster. In order to calculate the number of pairs of neurons that were significantly correlated within each dataset we first generated 1000 shuffled time courses for each neuron using MATLAB's randperm function.
Pairwise correlations for the randomly shuffled time courses were calculated in the same way as the original data, and a pair of neurons were considered correlated if their correlation coefficient in the original data was significantly different to the 1000 shuffled datasets with P < 0.05. To determine the threshold of simultaneous firing, the synchronization of the time shuffled data was calculated, and the threshold was set at the 99 th percentile of synchronization in the shuffled data.
Synchronization above this threshold was considered "synchronized". These data were then plotted on a normalized y-axis ranging from 0 (no synchronizations) to 1 (100% synchronization) and time on the x-axis. The total number of synchronizations, average synchronization amplitude, and average synchronization duration were then tabulated.
Extracellular recordings. Organoids were recorded between age day ~100-107. Live organoids were perfused with 500nM kainic acid in aCSF (containing in mM: NaCl 126, D-glucose 10, Table S1 specifies the number of non-contiguous sections imaged prior to selection of representative images. The n for all other representative images is specified in the figure legends.
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